Clinical Trials Browser

Completed × INDUSTRY × gadoteridol × Clear all

NCT03750188 2020-01-23

Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs

Central Nervous System Diseases, Central Nervous System Neoplasms

NCT00522951 2017-08-28

SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study

Phase 3 Completed

165 enrolled 24 charts

Brain Neoplasms